AKTX

Conviction 76HealthcareScan · Fri, Jun 26, 2026

Bullish harami

AKTX$9.92+4.20%

ResistanceSupportVol 14

Vol MA14 70.9K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Akari Therapeutics PlcPHARMACEUTICAL PREPARATIONSwww.akaritx.com ↗

Price9.92

Change+4.20%

Gap+3.36%

Rel volume0.02×

Avg volume109.5K

Avg $ vol1.52M

SMA 2013.30

SMA 509.45

SMA 2002.92

Price vs 50+4.99%

Price vs 200+239.98%

MA stackbullish

50/200 cross—

Supertrenddown · 15.64

RSI (14)44

MACD hist-0.83

MACD cross—

Stoch %K / %D7 / 4

ADX (14)37

+DI / −DI21 / 18

RSI divergence—

MACD divergence—

ATR %+20.69%

ADR %15.70%

52w high22.05

52w low0.1210

From 52w high-55.01%

Above 52w low+8098.35%

New 52w highNo

SqueezeOff

Bollinger width60.79%

%B0.08

Donchian pos2.55%

Donchian high25.95

Donchian low9.50

AVWAP (52w high)18.01

vs AVWAP high-44.92%

AVWAP (52w low)13.72

vs AVWAP low-27.67%

OBV trendDown

Chaikin MF (20)-0.44

Today vs 20d0.02×

Avg vol (14d)70.9K

Avg vol (20d)109.5K

Avg $ vol (20d)1.52M

Market cap—

RS 3m (vs SPY)+6857.46%

RS 6m (vs SPY)+3498.84%

RS line new highNo

Trend template7/8

Technical rank72.7

1 week-9.32%

1 month-37.71%

3 months+7172.73%

6 months+3944.03%

1 year+755.17%

YTD+3320.69%

P/E—

P/B—

P/S—

P/FCF—

EPS0.0000

Div yield—

ROE-120.29%

ROA-51.04%

Debt/Eq0.01

Current0.27

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth12.60%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value896.44B

Revenue—

Net income-14.46M

Gross profit—

Free cash flow-10.58M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees5

ListedFri, Dec 7, 2012

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction76 / 100

Pattern quality—

Tech rank72.7 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish harami

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AKTX

All disclosures →

No recent disclosed trades by Congress in AKTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AKTX · 9 buys

Insider	Side	Shares	Value	Traded	Filed
Gaslightwala Abizer CEO · Stock Option (Right to Buy) · 2026-06-24	Grant	5.5K	—	2026-06-24	2026-06-25
Gaslightwala Abizer CEO · Stock Option (Right to Buy) · 2026-06-24	Grant	15.56K	—	2026-06-24	2026-06-25
Farag Kameel D. Interim CFO · American Depositary Shares representing Ordinary Shares · 2026-06-24	Grant	1.25K	$13K	2026-06-24	2026-06-25
Farag Kameel D. Interim CFO · American Depositary Shares representing Ordinary Shares · 2026-06-24	Grant	1.4K	$13K	2026-06-24	2026-06-25
Farag Kameel D. Interim CFO · American Depositary Shares representing Ordinary Shares · 2026-06-24	Grant	1.57K	$13K	2026-06-24	2026-06-25
Farag Kameel D. Interim CFO · American Depositary Shares representing Ordinary Shares · 2026-06-24	Grant	2.54K	$13K	2026-06-24	2026-06-25
Farag Kameel D. Interim CFO · American Depositary Shares representing Ordinary Shares · 2026-06-24	Grant	3.73K	$13K	2026-06-24	2026-06-25
Farag Kameel D. Interim CFO · American Depositary Shares representing Ordinary Shares · 2026-06-24	Grant	7.35K	$28K	2026-06-24	2026-06-25
Farag Kameel D. Interim CFO · American Depositary Shares representing Ordinary Shares · 2026-06-24	Grant	1K	$13K	2026-06-24	2026-06-25

SEC filings

EDGAR filings in AKTX · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.